GH · Company research

Guardant Health, Inc. (GH): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 2026168.33$23,561,305,11022507836110.00———70.3368731976428303——

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.